Valuation and Due Diligence

Biomedical product and technology evaluation to support companies and their investors in due diligence and valuation

Read more

Health Economics

Economic analyses to inform stakeholders on the cost benefit and budgetary ramifications of health innovations

Read more

Commercialization Strategy

Market and commercialization strategies to satisfy payer requirements and drive clinical adoption by health professionals and medical facilities

Read more

Pricing and Reimbursement

US and International payer requirements for optimized coding, coverage and pricing determinations for pharmaceutical, device and diagnostic technologies

Read more

Clinical Practice Support

Optimized coding, billing, collections and operational strategies for facility and private medical practice

Read more

Welcome to Sentinel Consulting Group (SCG)

Sentinel Consulting Group (SCG) provides health economics and reimbursement planning for pharmaceutical, medical device, and diagnostic development companies. SCG also provides services and guidance for healthcare organizations, clinicians and medical facilities.

The Principal and Founder is a physician executive with over 12 years experience in medical finance, clinical practice management, business development and applied biomedical research. Sentinel Consulting Group was founded to assist life science and biomedical technology companies with the rigors of strategic focus for medical reimbursement and commercialization, and to provide clinicians and facilities with solutions for complex problems in practice management and healthcare delivery.

About Us

SCG emphasizes a multidisciplinary approach on behalf of clinicians, medical facilities and commercial development efforts to maximize strategic focus and financial return.

Read more about us

Health Industry

The healthcare industry in the United States and abroad is experiencing a period of profound change. These trends represent an opportunity for clinicians and organizations to provide enhanced clinical care and for business entrepreneurs to develop novel medical interventions and technologies. They also represent significant risk for those unable to assess and adapt within the changing sector landscape.

Read more